Literature DB >> 23547070

Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary.

Daniel S-W Tan1, Joey Montoya, Quan-Sing Ng, Kian-Sing Chan, Oon Lynette, Sai Sakktee Krisna, Angela Takano, Wan-Teck Lim, Eng-Huat Tan, Kiat-Hon Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23547070     DOI： 10.1200/JCO.2012.44.3937

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.

Authors:  John D Hainsworth; F Anthony Greco
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 2.  [The role of pathology in the diagnostics of CUP syndrome].

Authors:  A Stenzinger; M Kriegsmann; W Weichert
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

Review 3.  Cancer of Unknown Primary in the Molecular Era.

Authors:  Shumei Kato; Ahmed Alsafar; Vighnesh Walavalkar; John Hainsworth; Razelle Kurzrock
Journal:  Trends Cancer       Date:  2021-01-28

4.  Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.

Authors:  Zoran Gatalica; Sherri Z Millis; Semir Vranic; Ryan Bender; Gargi D Basu; Andreas Voss; Daniel D Von Hoff
Journal:  Oncotarget       Date:  2014-12-15

5.  Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary.

Authors:  Norma A Palma; Siraj M Ali; Jamie O'Connor; Deepa Dutta; Kai Wang; Salil Soman; Gary A Palmer; Deborah Morosini; Jeffrey S Ross; Doron Lipson; Phil J Stephens; Mayur Patel; Vincent A Miller; Nicholas Koutrelakos
Journal:  Case Rep Oncol       Date:  2014-07-23

6.  Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications.

Authors:  John D Hainsworth; F Anthony Greco
Journal:  Drugs Real World Outcomes       Date:  2016-03

7.  Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary.

Authors:  Li Lei; Jeremy K Deisch
Journal:  Case Rep Pathol       Date:  2016-11-24

8.  Putative lung adenocarcinoma with epidermal growth factor receptor mutation presenting as carcinoma of unknown primary site: A case report.

Authors:  Masahiro Yamasaki; Kunihiko Funaishi; Naomi Saito; Ayaka Sakano; Megumu Fujihara; Wakako Daido; Sayaka Ishiyama; Naoko Deguchi; Masaya Taniwaki; Nobuyuki Ohashi; Noboru Hattori
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

9.  Genetic characterisation of molecular targets in carcinoma of unknown primary.

Authors:  B Clynick; B Dessauvagie; G Sterrett; N T Harvey; R J N Allcock; C Saunders; W Erber; K Meehan
Journal:  J Transl Med       Date:  2018-07-04       Impact factor: 5.531

10.  Changing histopathological diagnostics by genome-based tumor classification.

Authors:  Michael Kloth; Reinhard Buettner
Journal:  Genes (Basel)       Date:  2014-05-28       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.